MINION
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

MINION Trademark

Serial Number: 79131861 • Registration: 4650844

MINION is a trademark filed by Oxford Nanopore Technologies PLC on November 16, 2012. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Oxford Nanopore Technologies PLC (19 trademarks)

Gosling Building,

Entity Type: 98

Oxford Nanopore Technologies Limited

Edmund Cartwright House
Oxford OX44GA , GB

Entity Type: 99

Trademark Details

Filing Date

November 16, 2012

Registration Date

December 9, 2014

Published for Opposition

September 23, 2014

Cancellation Date

March 6, 2026

Goods & Services

Medical and veterinary apparatus for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; portable medical and veterinary apparatus for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; blood testing apparatus; diagnostic apparatus for medical or veterinary purposes for pregnancy testing, and for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; portable diagnostic apparatus for medical or veterinary purposes for pregnancy testing and for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; testing apparatus for medical or veterinary purposes for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; portable testing apparatus for medical or veterinary purposes for pregnancy testing and for detecting for pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; empty cartridges for test samples, namely, cartridges for use with concentrates and solutions in solid or liquid form samples for medical testing use; reaction units containing chemical reagents, for medical testing purposes; parts and fittings for all the aforesaid goods

[ Scientific and technological services and research and design relating thereto, namely, consultation, research and design services relating to automated systems and instruments for direct electrical detection and analysis of molecules for use in the field of genomics, protein analysis, molecular analysis, life sciences, healthcare, security and defence; industrial analysis and research services in the field of genomics, protein analysis, molecular analysis, life sciences, healthcare, security and defence; scientific research for chemical, biochemical, biological, bacteriological, medical or veterinary purposes; biological, chemical, biochemical, bacteriological, DNA, RNA, protein, polynucleic acid and molecular analysis services, namely, biological, chemical, biochemical, bacteriological DNA, RNA, protein, polynucleic acid and molecular analysis for scientific or research purposes; design and development of instruments and apparatus for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; laboratory testing services for chemical, biochemical, biological, bacteriological, molecular analysis, medical or veterinary purposes; DNA and polynucleic acid testing services for scientific or research purposes; information and advice regarding all the aforesaid services ]

Reagents for veterinary or medical use; reagents for use in automated test systems for veterinary or medical use; reagents, namely, reagents for use in blood grouping, molecular biology, bacteriological, biotechnology and microbiological analysis, including reagents for formation of amphipathic membranes, buffer solutions, non-aqueous solvents, and surfactants, all for medical or veterinary use; reagents for medical and veterinary diagnosis; reagents for laboratory tests for medical or veterinary purposes; reagents for medical or veterinary use, namely, reagents for immunoassay analysers; reagents for medical or veterinary use, namely, reagents for testing aqueous solutions; medical and veterinary diagnostic reagents for testing for susceptibility to allergies; reagents for medical or veterinary use, namely, reagents for use in biological processing; reagents for medical or veterinary use, namely, reagents for use in nucleic acid characterisation and nucleic acid sequencing; reagents for medical or veterinary use, namely, reagents for protein identification and analysis; [ reagents for medical or veterinary use, namely, reagents for formation of amphipathic membranes; blood substitute in the form of buffer solutions for medical and veterinary use; aqueous solvents for use in tests for medical and veterinary purposes; non-aqueous solvents for use in tests for medical and veterinary purposes; non-aqueous media in the nature of solid or liquid non-aqueous solutions for use in tests for medical and veterinary purposes; surfactants for use in tests for medical and veterinary purposes; silicone oils for use in tests for medical and veterinary purposes; ] enzymes for use in tests for medical and veterinary purposes; proteins for use in tests, all the foregoing for medical and veterinary purposes

Apparatus and instruments for biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis, namely, automated instruments for detecting the presence, properties and identity of analytes, comprising cartridges, microarrays, silicon chip based arrays, ASICs (application specific integrated circuits), and networked computer hardware and software for performing and controlling the analysis, and for processing, displaying and storing the information obtained from the analysis for scientific or research purposes; portable apparatus and instruments for biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis, namely, microarrays, and silicon chip based arrays for scientific or research purposes; apparatus and instruments for use in laboratory analysis, namely, empty cartridges for test samples, namely, cartridges for use with concentrates and solutions in solid or liquid form samples for scientific or research testing use; diagnostic and testing apparatus, for testing air quality, food, soil or water, not for medical purposes; computer programs, computer hardware and data processing apparatus, all for the analysis and recordal of scientific data; portable computer hardware and data processing apparatus, all for the analysis and recordal of scientific data; computer peripheral devices; instruments and apparatus for the display of information obtained from scientific equipment, namely, electronic display interfaces; silicon chips; DNA chips; microarray chips; analyte detector chips for scientific or research use; biosensor chips for scientific or research use; laboratory equipment, namely, empty cartridges for use with concentrates and solutions in solid or liquid form samples for use in biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis; batteries; rechargeable batteries; chargers for batteries; power packs consisting of batteries; computer docking stations; apparatus for connecting and charging portable digital electronic devices; diagnostic apparatus incorporating chemical or biological reagents for testing air quality, food, soil or water; reaction systems containing chemical or biological reagents for laboratory use; parts and fittings for all the aforesaid goods

Reagents for use in automated test systems for non-medical purposes; reagents for analytical tests for non-medical purposes; reagents for industrial use, namely, for food testing, soil testing, water testing and air quality testing; reagents for use in science; reagents for laboratory use; reagents for use in molecular biology, biotechnology, microbiology, and bacteriology; reagents for nucleic acid amplification; reagents for use in forensic analysis; [ reagents for research purposes in the field of blood grouping; ] reagents for use in environmental testing and environmental analysis; reagents for testing water and other liquids; reagents for testing aqueous solutions; reagents for processing biological elements prior to their use with or analysis by scientific apparatus; reagents for use in nucleic acid characterisation and nucleic acid sequencing for non-medical purposes; reagents for protein identification and analysis for non-medical purposes; chemicals for use in tests to detect diseases in plant life; reagents for formation of amphipathic membranes; chemicals, namely, buffer solutions for scientific or research use; [ aqueous solvents for industrial and commercial use; non-aqueous solvents for industrial and commercial use; ] non-aqueous media in the nature of solid or liquid non-aqueous solutions for scientific or research use; [ surfactants for use in analytical tests for scientific or research use; silicone oils for analytical tests for scientific or research use; silicone fluids; ] enzymes for scientific and research purposes and use in analytical tests; proteins for use in analytical tests for scientific or research use; chemical diagnostic reagents for scientific use, all the foregoing for other than medical and veterinary purposes; reagents for medical and veterinary research; nucleic acid amplification reagents for medical research or forensic use

Filing History

CANCELLED SECTION 71
Mar 6, 2026 C71T
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 1, 2024 ADCH
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Dec 9, 2023 REM4
FINAL DECISION TRANSACTION PROCESSED BY IB
May 23, 2023 FINP
GENERIC MADRID TRANSACTION SENT TO IB
Mar 21, 2023 XXSS
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Mar 21, 2023 INNA
GENERIC MADRID TRANSACTION CREATED
Mar 21, 2023 XXCR
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 27, 2022 FINV
INTERNATIONAL REGISTRATION RENEWED
Dec 5, 2022 RNWL
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 3, 2022 INPR
NOTIFICATION PROCESSED BY IB
May 30, 2022 GPNX
REFUSAL PROCESSED BY IB
Dec 5, 2021 RFNT
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Dec 1, 2021 NA75
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Dec 1, 2021 C75P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 29, 2021 APRE
NEW REPRESENTATIVE AT IB RECEIVED
Nov 10, 2021 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 10, 2021 ADCH
TEAS SECTION 71 & 15 RECEIVED
Jun 8, 2021 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Dec 9, 2019 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Oct 25, 2019 NREP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 13, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 13, 2016 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 10, 2016 TCCA
FINAL DECISION TRANSACTION PROCESSED BY IB
May 16, 2015 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 30, 2015 FICS
FINAL DISPOSITION PROCESSED
Apr 30, 2015 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 9, 2015 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 9, 2014 R.PR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 24, 2014 TCCA
PUBLISHED FOR OPPOSITION
Sep 23, 2014 PUBO
NEW REPRESENTATIVE AT IB RECEIVED
Sep 11, 2014 NREP
NOTICE OF PUBLICATION
Sep 3, 2014 NPUB
NOTICE OF PUBLICATION
Sep 3, 2014 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 19, 2014 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 19, 2014 CNSA
EXAMINERS AMENDMENT MAILED
Aug 12, 2014 CNEA
EXAMINER'S AMENDMENT ENTERED
Aug 11, 2014 XAEC
EXAMINERS AMENDMENT -WRITTEN
Aug 11, 2014 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 31, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 31, 2014 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jul 31, 2014 ERFR
FINAL REFUSAL MAILED
Feb 18, 2014 CNFR
FINAL REFUSAL WRITTEN
Feb 14, 2014 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 6, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 6, 2014 CRFA
TEAS VOLUNTARY AMENDMENT RECEIVED
Feb 4, 2014 PARI
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 3, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 3, 2014 CRFA
ASSIGNED TO LIE
Feb 3, 2014 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 23, 2014 TROA
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Aug 26, 2013 CORR
CORRECTION TRANSACTION RECEIVED FROM IB
Aug 23, 2013 CRCV
REFUSAL PROCESSED BY IB
Aug 11, 2013 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 23, 2013 RFCS
REFUSAL PROCESSED BY MPU
Jul 22, 2013 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 19, 2013 RFCR
NON-FINAL ACTION WRITTEN
Jul 18, 2013 CNRT
APPLICATION FILING RECEIPT MAILED
Jul 13, 2013 MAFR
ASSIGNED TO EXAMINER
Jul 9, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 9, 2013 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 4, 2013 REPR